Prevention of Noise-induced Damage by Use of Antioxidants
- Conditions
- Noise-induced Hearing LossNoise-induced Tinnitus
- Interventions
- Drug: Antioxidantia
- Registration Number
- NCT01727492
- Lead Sponsor
- University Hospital, Antwerp
- Brief Summary
The current study is a dubble-blinde placebo-controlled cross-over study verifying the preventive effect of antioxidants on noise-induced hearing loss (NIHL) and noise-induced tinnitus (NIT). The antioxidants comprise of a mixture of magnesium and n-acetylcystein which should be taken 1h before leisure noise above 100dB for at least 30 minutes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Age: 18-25 years old
- Temporary tinnitus after noise exposure: loudness >5 on a VAS
- middle ear problems
- Allergy for magnesium or n-acetylcystein
- Use of hearing protection when going out
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Antioxidantia Antioxidantia Dosage: 600mg n-acetylcystein and 200mg magnesium intake: 1 hour before leisure noise exposure above 100dB of at least 30 minutes frequency: 4 separate events (2x placebo, 2x antioxidants)
- Primary Outcome Measures
Name Time Method Protection against noise-induced tinnitus due to antioxidants Antioxidants protect against temporary threshold shift. The most prevalent cause of noise-induced tinnitus is noise-induced hearing loss. Therefore, it is assumed that the preventive intake of antioxidants prior to a loud event, might protect against threshold shift as well as noise-induced tinnitus.
A 50% decrease of tinnitus loudness scored on a Visual Analogue Scale (VAS) compared to placebo trials is expected.
- Secondary Outcome Measures
Name Time Method Change of tinnitus duration It is expected that with the intake of antioxidants noise-induced tinnitus is prevented or reduced after loud music exposure. In addition, it is expected that the tinnitus persistence is shortened compared to the placebo arm.
Trial Locations
- Locations (1)
Antwerp University Hospital
🇧🇪Antwerp, Edegem, Belgium